Table 1.
Characteristics of the study population from the third cross-sectional assessment
| Characteristics | N = 2216 |
|---|---|
| Age, years | 73.74 ± 23.26 |
| Gender, male | 915 (41.3%) |
| Systolic blood pressure, mmHg | 153.08 ± 71.13 |
| Diastolic blood pressure, mmHg | 82.41 ± 74.13 |
| Body mass index, kg m−2 | 73.74 ± 7.02 |
| Total cholesterol/HDL, mmol l−1 | 10.59 ± 23.26 |
| Cardiovascular disease, yes | 437 (19.7%) |
| Stroke, yes | 128 (5.8%) |
| Smoking, current/past/never | 329/1110/758 |
| ACE gene, DD/ID/II | 570/1130/464 |
| AGT gene, MM/MT/TT | 760/963/333 |
| AGTR1 gene, CC/CT/TT | 559/995/478 |
| Use of ACE-inhibitors, 0/0–4/≥4 years | 1489/495/232 |
| Use of β-blockers, 0/0–4/≥4 years | 949/773/494 |
| Use of other antihypertensive drugs | 1556 (70.2%) |
| No antihypertensive drug | 197 (8.9%) |
| Use of statins | 489 (32.1%) |
| Use of coumarins | 162 (7.3%) |